GlassScriptPhysician profile
Lisa K Davis
NPI 1629207808
$80,507.28
in general payments reported to CMS, 2019-2025
34 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18K · 2022: $10K · 2023: $17K · 2024: $20K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Food and Beverage: $7,018 · Travel and Lodging: $2,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,000.00 |
| Food and Beverage | $7,018.46 |
| Travel and Lodging | $2,216.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $75,827.34 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $1,307.31 | 2021-2025 | Watchman Flx |
| Novo Nordisk INC | $392.74 | 2022-2025 | Wegovy, Ozempic |
| Cleerly, INC. | $297.77 | 2023-2025 | Cleerly Labs, Cleerly Ischemia |
| Lilly USA, LLC | $247.92 | 2024-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $242.18 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $216.74 | 2023-2024 | Optimizer, Optimizer |
| Kestra Medical Technology Services, INC. | $196.71 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $191.91 | 2023-2025 | Farxiga, Wainua |
| Medtronic, INC. | $150.00 | 2023 | Cobalt Dr Mri Surescan |
| Pfizer INC. | $146.48 | 2021-2025 | |
| Harmony Biosciences LLC | $145.32 | 2023-2025 | Wakix |
| Heartflow, INC. | $141.87 | 2023 | Ffrct |
| Kiniksa Pharmaceuticals International, Plc | $116.15 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $115.34 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.16 | 2021-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $85.08 | 2023 | |
| Jazz Pharmaceuticals INC. | $82.22 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $56.22 | 2022-2025 | Camzyos |
| Corcept Therapeutics | $49.96 | 2024 | Korlym |
| Abiomed | $45.85 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $37.11 | 2025 | Evkeeza |
| Merck Sharp & Dohme LLC | $34.35 | 2023-2024 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $34.00 | 2024 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $33.42 | 2021-2023 | Xarelto |
| 3b Medical, INC. | $29.76 | 2024 | Luna |
| Ionis Pharmaceuticals, INC. | $26.98 | 2025 | Tryngolza |
| Biosense Webster, INC. | $26.73 | 2024 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.07 | 2025 | Jardiance |
| Fisher & Paykel Healthcare INC | $25.00 | 2024 | Fisher & Paykel Healthcare |
| Esperion Therapeutics, INC. | $20.30 | 2023 | Nexletol |
| Abbott Laboratories | $20.25 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.52 | 2021 | |
| Chiesi USA, INC. | $18.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.